Effects of CB1R Inverse Agonist, INV-202, in Patients with Features of Metabolic Syndrome. A Randomized, Placebo-Controlled, Double-Blind Phase 1b Study
DIABETES OBESITY & METABOLISM（2024）
关键词
CB1R inverse agonist,metabolic syndrome,weight loss
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要